Published on Web 03/12/2002
Synthesis and Characterization of Oligodeoxynucleotides
Containing Formamidopyrimidine Lesions and
Nonhydrolyzable Analogues
Kazuhiro Haraguchi, Michael O. Delaney, Carissa J. Wiederholt,
Aruna Sambandam, Zsolt Hantosi, and Marc M. Greenberg*
Contribution from the Department of Chemistry, Colorado State UniVersity,
Fort Collins, Colorado 80523
Received September 6, 2001
Abstract: Oligodeoxynucleotides containing formamidopyrimidine lesions and C-nucleoside analogues at
defined sites were prepared by solid-phase synthesis and in some cases enzymatic ligation. Formami-
dopyrimidine lesions were introduced as dinucleotides to prevent rearrangement to their pyranose isomers.
Oligodeoxynucleotides containing single diastereomers of C-nucleoside analogues of Fapy‚dA were
introduced by using the respective phosphoramidites. The formamidopyrimidine lesions reduce the TM of
dodecamers relative to their unmodified nucleotide counterparts when opposite the nucleotide proper base-
pairing partner. However, duplexes containing Fapy‚dG-dA mispairs melt significantly higher than those
comprised of dG-dA. All duplexes containing Fapy‚dA-dX or its C-nucleoside analogue melt lower than the
respective complexes containing dA-dX. Studies of the alkaline lability of oligodeoxynucleotides containing
formamidopyrimidine lesions indicate that Fapy‚dA is readily identified as an alkali-labile lesion with use of
piperidine (1.0 M, 90 °C, 20 min), but Fapy‚dG is less easily identified in this manner.
DNA undergoes a variety of chemically induced structural
changes when exposed to reactive oxygen species (e.g. hydroxyl
radical) and other chemical agents.1,2 Many of the lesions
produced in DNA result from attack by radicals and other
electrophiles on the nucleobases and are involved in aging and
diseases such as cancer.3 The effects of these lesions on
polymerase enzyme activity and their recognition by DNA repair
enzymes are critical in determining their biological role.4 These
interactions are a manifestation of the lesions’ structures and
their effect on the shape and stability of the DNA duplex as a
whole. Synthesis of a biopolymer containing a specific lesion
at a defined site provides a valuable tool for elucidating the
structural and functional properties of damaged DNA. Although
synthesis of unmodified nucleic acids is routine, preparation of
DNA containing damaged nucleotides can be challenging due
to the decreased stability of a lesion to synthesis and deprotection
conditions.5,6
recognized by a variety of DNA repair enzymes.7 γ-Radiolysis
produces Fapy‚dG in greater amounts in vivo than the respective
8-oxopurine lesion (OxodG), which is formed from a common
intermediate (Scheme 1).8 Fapy‚dA and 8-oxodeoxyadenosine
(OxodA) are formed via an analogous mechanism. The effects
of formamidopyrimidines on polymerase enzymes are uncertain,
but evidence suggests that both are premutagenic lesions.9
Cleavage of the purine imidazole ring in deoxyadenosine and
deoxyguanosine introduces additional functional groups and a
greater number of degrees of freedom in the formamidopyri-
midine lesions than are present in the native nucleotides or the
8-oxopurines. This expands the number of possible hydrogen
bonding motifs that can interact with enzymes, but also increases
the synthetic challenge. Synthesis of oligodeoxynucleotides
containing Fapy‚dA and Fapy‚dG are complicated by the fact
that the monomeric species readily isomerize to their pyranose
congeners.10 We developed an approach that overcomes this
and other obstacles and enables one to synthesize an oligode-
The formamidopyrimidines are examples of DNA lesions that
are of biological and chemical interest. These lesions are
(6) (a) For a recent review see: Butenandt, J.; Burgdorf, L. T.; Carrell, T.
Synthesis 1999, 1085. (b) Taylor, J.-S.; O’Day, C. L. J. Am. Chem. Soc.
1989, 111, 401. (c) Shibutani, S.; Takeshita, M.; Grollman, A. P. Nature
1991, 349, 431. (d) Iwai, S.; Shimizu, M.; Kamiya, H.; Ohtsuka, E. J. Am.
Chem. Soc. 1996, 118, 7642. (e) Kobertz, W. R.; Essigmann, J. M. J. Am.
Chem. Soc. 1997, 119, 5960. (f) Sambandam, A.; Greenberg, M. M. Nucleic
Acids Res. 1999, 27, 3597. (g) Iwai, S. Angew. Chem., Int. Ed. 2000, 39,
3874.
(7) (a) Boiteux, S.; Gajewski, E.; Laval, J.; Dizdaroglu, M. Biochemistry 1992,
31, 106. (b) Krakaya, A.; Jaruga, P.; Bohr, V. A.; Grollman, A. P.;
Dizdaroglu, M. Nucleic Acids Res. 1997, 25, 474. (c) Dizdaroglu, M.;
Bauche, C.; Rodriguez, H.; Laval, J. Biochemistry 2000, 39, 5586.
(8) Pouget, J.-P.; Douki, T.; Richard, M.-J.; Cadet, J. Chem. Res. Toxicol. 2000,
13, 541.
(1) (a) von Sonntag, C. The Chemical Basis of Radiation Biology; Taylor and
Francis: London, 1987. (b) Greenberg, M. M. Chem. Res. Toxicol. 1998,
11, 1235. (c) Greenberg, M. M. In ComprehensiVe Natural Products
Chemistry, Vol. 7, DNA and Aspects of Molecular Biology; Kool, E. T.,
Ed.; Pergamon: Oxford, 1999; pp 371-426.
(2) Gates, K. S. In ComprehensiVe Natural Products Chemistry, Vol. 7, DNA
and Aspects of Molecular Biology; Kool, E. T., Ed.; Pergamon: Oxford,
1999; pp 491-552.
(3) (a) Hoeijmakers, J. H. Nature 2001, 411, 366. (b) DePinho, R. A. Nature
2000, 408, 248.
(4) (a) Lindahl, T.; Wood, R. D. Science 1999, 286, 1897. (b) Laval, J.; Jurado,
J.; Saparbaev, M.; Sidokina, O. Mutation Res. 1998, 402, 93. (c) Delaney,
J. C.; Essigmann, J. M. Chem. Biol. 1999, 6, 743. (d) Wang, D.; Kreutzer,
D. A.; Essigmann, J. M. Mutat. Res. 1998, 400, 99.
(9) Graziewicz, M.-A.; Zastawny, T. H.; Oli’nski, R.; Tudek, B. Mutation Res.
1999, 434, 41.
(10) (a) Raoul, S.; Bardet, M.; Cadet, J. Chem. Res. Toxicol. 1995, 8, 924. (b)
Berger, M.; Cadet, J. Z. Naturforsch. 1985, 40b, 1519.
(5) Iyer, R. P.; Beaucage, S. L. In ComprehensiVe Natural Products Chemistry;
Kool, E. T., Ed.; Pergamon: Amsterdam, 1999; Vol. 7, pp 105-152.
9
10.1021/ja012135q CCC: $22.00 © 2002 American Chemical Society
J. AM. CHEM. SOC. 2002, 124, 3263-3269
3263